Company Overview
By using the body’s immune system, Anixa Biosciences is taking multiple approaches to fighting cancer—developing both diagnostics and therapeutics to detect cancer early, when it is most curable, and to treat those afflicted once diagnosed.
Recent News
Anixa Biosciences Announces Notice of Allowance of Additional Patent on Breast Cancer Vaccine Technology
Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Clinical and Experimental Vaccine Research Highlighting Ovarian Cancer Vaccine Technology
Anixa Biosciences to Present at the 2022 H.C. Wainwright Global Investment Conference
Stock Overview
Symbol
ANIX
Exchange
Nasdaq
Market Cap
123.71m
Last Price
$4.06
52-Week Range
$2.30 - $5.87
08/12/2022 03:59 PM EDT
Investor Relations
Mike Catelani
Chief Operating Officer & Chief Financial Officer
T: 408-708-9808